Gabelli Healthcare & WellnessRx Trust
Sponsor: Gabelli / GAMCO · Inception Jun 19, 2007 · Pays quarterly
Market priceShare price
$9.91
+2.38% (+$0.23)
NAVAsset value per share
—
as of —
Premium / discountPrice vs. assets
NAV unavailable
Close vs NAV, Oct 15, 2026
Distribution rate (price)Payout rate
6.86%
regular, annualised · on NAV —
Expense ratioAnnual cost
Not reported
no tagged fee table
LeverageBorrowing
Not reported
senior securities not tagged
Quote status: Market closed — last regular-session price · last trade Oct 15, 2026, 4:00 PM EDT (exchange time, ET) · retrieved Oct 15, 2026, 10:43 PM EDTRegular-session prices; extended-hours quotes are not displayed.
Full portfolio as filed on SEC Form N-PORT for the month ending Jun 30, 2026, filed Aug 31, 2026. 195 positions; weights are percent of net assets as reported. Weights sum to 100.0% — leverage, cash, derivatives and short positions mean totals need not equal 100%. This is a historical report, not a live portfolio.
Top 10 holdings
| # | Security | Type | Country | Weight | Value (USD) |
|---|---|---|---|---|---|
| 1 | UNITED STATES OF AMERICA - BUREAU OF THE PUBLIC DEBT | Debt | United States | 3.47% | $7.9M |
| 2 | UNITED STATES OF AMERICA - BUREAU OF THE PUBLIC DEBT | Debt | United States | 3.44% | $7.9M |
| 3 | UNITED STATES OF AMERICA - BUREAU OF THE PUBLIC DEBT | Debt | United States | 2.73% | $6.2M |
| 4 | UNITED STATES OF AMERICA - BUREAU OF THE PUBLIC DEBT | Debt | United States | 2.73% | $6.2M |
| 5 | ABBVIE INC | Equity | United States | 2.63% | $6M |
| 6 | UNITED STATES OF AMERICA - BUREAU OF THE PUBLIC DEBT | Debt | United States | 2.49% | $5.7M |
| 7 | MERCK & COMPANY INC | Equity | United States | 2.47% | $5.6M |
| 8 | UNITED STATES OF AMERICA - BUREAU OF THE PUBLIC DEBT | Debt | United States | 2.38% | $5.4M |
| 9 | UNITED STATES OF AMERICA - BUREAU OF THE PUBLIC DEBT | Debt | United States | 2.36% | $5.4M |
| 10 | TEVA PHARMACEUTICAL INDUSTRIES LTD | Equity | Israel | 1.74% | $4M |
Asset class
| Asset class | % net assets | Value |
|---|---|---|
| Equity (common) | 65.89% | $150M |
| Debt | 34.11% | $77.9M |
Country (top 12)
| Country (top 12) | % net assets | Value |
|---|---|---|
| United States | 86.46% | $197M |
| Japan | 2.39% | $5.5M |
| United Kingdom | 2.16% | $4.9M |
| Ireland | 2.08% | $4.8M |
| Israel | 1.74% | $4M |
| Canada | 1.68% | $3.8M |
| Switzerland | 1.62% | $3.7M |
| France | 1.46% | $3.3M |
| Cayman Islands | 0.21% | $470K |
| Hong Kong | 0.13% | $289K |
| Netherlands | 0.07% | $156K |
Region
| Region | % net assets | Value |
|---|---|---|
| United States | 86.46% | $197M |
| Developed Europe | 7.39% | $16.9M |
| Japan | 2.39% | $5.5M |
| Middle East | 1.74% | $4M |
| Canada | 1.68% | $3.8M |
| Offshore domiciles | 0.21% | $470K |
| Asia ex-Japan | 0.13% | $289K |
Issuer type
| Issuer type | % net assets | Value |
|---|---|---|
| Corporate | 65.89% | $150M |
| U.S. Treasury | 34.11% | $77.9M |
Fair-value level
| Fair-value level | % net assets | Value |
|---|---|---|
| Level 1 | 65.84% | $150M |
| Level 2 | 34.16% | $78M |
Level 3 = valued with unobservable inputs (typically private or illiquid).
Long / short
| Long / short | % net assets | Value |
|---|---|---|
| Long | 100.00% | $228M |
All allocation percentages use net assets as the denominator (N-PORT convention). A position's share of invested assets may differ from its share of the whole fund including cash and leverage.
All 195 positions
| Security | Identifier | Type | Issuer | Country | Balance | Units | Value (USD) | Weight | FV level |
|---|---|---|---|---|---|---|---|---|---|
| UNITED STATES OF AMERICA - BUREAU OF THE PUBLIC DEBT | 912797UH8 | Debt | UST | United States | 8,000,000 | principal | $7.9M | 3.47% | 2 |
| UNITED STATES OF AMERICA - BUREAU OF THE PUBLIC DEBT | 912797TC1 | Debt | UST | United States | 8,000,000 | principal | $7.9M | 3.44% | 2 |
| UNITED STATES OF AMERICA - BUREAU OF THE PUBLIC DEBT | 912797UP0 | Debt | UST | United States | 6,250,000 | principal | $6.2M | 2.73% | 2 |
| UNITED STATES OF AMERICA - BUREAU OF THE PUBLIC DEBT | 912797VK0 | Debt | UST | United States | 6,300,000 | principal | $6.2M | 2.73% | 2 |
| ABBVIE INC | 00287Y109 | Equity | CORP | United States | 23,900 | shares | $6M | 2.63% | 1 |
| UNITED STATES OF AMERICA - BUREAU OF THE PUBLIC DEBT | 912797SA6 | Debt | UST | United States | 5,750,000 | principal | $5.7M | 2.49% | 2 |
| MERCK & COMPANY INC | 58933Y105 | Equity | CORP | United States | 43,850 | shares | $5.6M | 2.47% | 1 |
| UNITED STATES OF AMERICA - BUREAU OF THE PUBLIC DEBT | 912797VJ3 | Debt | UST | United States | 5,550,000 | principal | $5.4M | 2.38% | 2 |
| UNITED STATES OF AMERICA - BUREAU OF THE PUBLIC DEBT | 912797TF4 | Debt | UST | United States | 5,400,000 | principal | $5.4M | 2.36% | 2 |
| TEVA PHARMACEUTICAL INDUSTRIES LTD | 881624209 | Equity | CORP | Israel | 117,500 | shares | $4M | 1.74% | 1 |
| CIGNA GROUP (THE) | 125523100 | Equity | CORP | United States | 13,800 | shares | $3.8M | 1.67% | 1 |
| BRIDGEBIO PHARMA INC | 10806X102 | Equity | CORP | United States | 51,000 | shares | $3.8M | 1.66% | 1 |
| HALOZYME THERAPEUTICS INC | 40637H109 | Equity | CORP | United States | 43,200 | shares | $3.4M | 1.48% | 1 |
| NESTLE' SA/AG | CH0038863350 | Equity | CORP | Switzerland | 32,200 | shares | $3.3M | 1.45% | 1 |
| CENCORA INC | 03073E105 | Equity | CORP | United States | 11,550 | shares | $3.3M | 1.43% | 1 |
| UNITED STATES OF AMERICA - BUREAU OF THE PUBLIC DEBT | 912797TQ0 | Debt | UST | United States | 3,200,000 | principal | $3.2M | 1.40% | 2 |
| UNITED STATES OF AMERICA - BUREAU OF THE PUBLIC DEBT | 912797SK4 | Debt | UST | United States | 3,200,000 | principal | $3.2M | 1.38% | 2 |
| COOPER COMPANIES INC (THE) | 216648501 | Equity | CORP | United States | 42,700 | shares | $3.1M | 1.34% | 1 |
| CHEMED CORP | 16359R103 | Equity | CORP | United States | 6,500 | shares | $3M | 1.33% | 1 |
| Kerry Group PLC | IE0004906560 | Equity | CORP | Ireland | 32,500 | shares | $3M | 1.30% | 1 |
| AMGEN INC | 031162100 | Equity | CORP | United States | 7,900 | shares | $2.9M | 1.25% | 1 |
| UNITED STATES OF AMERICA - BUREAU OF THE PUBLIC DEBT | 912797SU2 | Debt | UST | United States | 2,825,000 | principal | $2.8M | 1.22% | 2 |
| ASTRAZENECA PLC | GB0009895292 | Equity | CORP | United Kingdom | 14,650 | shares | $2.8M | 1.22% | 1 |
| UNITED STATES OF AMERICA - BUREAU OF THE PUBLIC DEBT | 912797RS8 | Debt | UST | United States | 2,710,000 | principal | $2.7M | 1.18% | 2 |
| UNITED STATES OF AMERICA - BUREAU OF THE PUBLIC DEBT | 912797TY3 | Debt | UST | United States | 2,695,000 | principal | $2.7M | 1.17% | 2 |
| LANTHEUS HOLDINGS INC | 516544103 | Equity | CORP | United States | 24,000 | shares | $2.7M | 1.17% | 1 |
| BRISTOL-MYERS SQUIBB COMPANY | 110122108 | Equity | CORP | United States | 45,000 | shares | $2.6M | 1.14% | 1 |
| OPTION CARE HEALTH INC | 68404L201 | Equity | CORP | United States | 122,500 | shares | $2.6M | 1.13% | 1 |
| POST HOLDINGS INC | 737446104 | Equity | CORP | United States | 28,000 | shares | $2.5M | 1.08% | 1 |
| SENSIENT TECHNOLOGIES CORP | 81725T100 | Equity | CORP | United States | 20,000 | shares | $2.5M | 1.08% | 1 |
| JOHNSON & JOHNSON | 478160104 | Equity | CORP | United States | 9,700 | shares | $2.5M | 1.08% | 1 |
| UNITED STATES OF AMERICA - BUREAU OF THE PUBLIC DEBT | 912797VA2 | Debt | UST | United States | 2,500,000 | principal | $2.5M | 1.08% | 2 |
| BAUSCH + LOMB CORP | 071705107 | Equity | CORP | Canada | 144,000 | shares | $2.4M | 1.04% | 1 |
| MCKESSON CORP | 58155Q103 | Equity | CORP | United States | 3,120 | shares | $2.4M | 1.03% | 1 |
| HENRY SCHEIN INC | 806407102 | Equity | CORP | United States | 27,700 | shares | $2.3M | 1.01% | 1 |
| ZIMMER BIOMET HOLDINGS INC | 98956P102 | Equity | CORP | United States | 26,500 | shares | $2.3M | 1.00% | 1 |
| UNITED STATES OF AMERICA - BUREAU OF THE PUBLIC DEBT | 912797RF6 | Debt | UST | United States | 2,250,000 | principal | $2.2M | 0.98% | 2 |
| UNITED STATES OF AMERICA - BUREAU OF THE PUBLIC DEBT | 912797UJ4 | Debt | UST | United States | 2,250,000 | principal | $2.2M | 0.98% | 2 |
| KIKKOMAN CORP | JP3240400006 | Equity | CORP | Japan | 215,000 | shares | $2.2M | 0.97% | 1 |
| DANONE SA | FR0000120644 | Equity | CORP | France | 26,743 | shares | $2.2M | 0.96% | 1 |
| CVS HEALTH CORP | 126650100 | Equity | CORP | United States | 20,550 | shares | $2.1M | 0.93% | 1 |
| UNITEDHEALTH GROUP INC | 91324P102 | Equity | CORP | United States | 5,105 | shares | $2.1M | 0.93% | 1 |
| LABCORP HOLDINGS INC | 504922105 | Equity | CORP | United States | 7,100 | shares | $2M | 0.87% | 1 |
| TENET HEALTHCARE CORP | 88033G407 | Equity | CORP | United States | 9,900 | shares | $1.9M | 0.81% | 1 |
| YAKULT HONSHA CO LTD | JP3931600005 | Equity | CORP | Japan | 106,000 | shares | $1.8M | 0.78% | 1 |
| INGLES MARKETS INC | 457030104 | Equity | CORP | United States | 20,000 | shares | $1.8M | 0.78% | 1 |
| UNITED STATES OF AMERICA - BUREAU OF THE PUBLIC DEBT | 912797VG9 | Debt | UST | United States | 1,800,000 | principal | $1.8M | 0.77% | 2 |
| UNILEVER PLC | 904767803 | Equity | CORP | United Kingdom | 29,000 | shares | $1.7M | 0.76% | 1 |
| INTEGER HOLDINGS CORP | 45826H109 | Equity | CORP | United States | 18,500 | shares | $1.7M | 0.76% | 1 |
| J.M. SMUCKER COMPANY (THE) | 832696405 | Equity | CORP | United States | 15,000 | shares | $1.7M | 0.74% | 1 |
| UNITED STATES OF AMERICA - BUREAU OF THE PUBLIC DEBT | 912797UF2 | Debt | UST | United States | 1,665,000 | principal | $1.7M | 0.72% | 2 |
| VERTEX PHARMACEUTICALS INC | 92532F100 | Equity | CORP | United States | 3,200 | shares | $1.6M | 0.70% | 1 |
| ABBOTT LABORATORIES | 002824100 | Equity | CORP | United States | 17,200 | shares | $1.6M | 0.68% | 1 |
| STRYKER CORP | 863667101 | Equity | CORP | United States | 4,800 | shares | $1.5M | 0.66% | 1 |
| ICU MEDICAL INC | 44930G107 | Equity | CORP | United States | 10,000 | shares | $1.5M | 0.64% | 1 |
| UNITED STATES OF AMERICA - BUREAU OF THE PUBLIC DEBT | 912797UY1 | Debt | UST | United States | 1,450,000 | principal | $1.4M | 0.63% | 2 |
| THERMO FISHER SCIENTIFIC INC | 883556102 | Equity | CORP | United States | 2,845 | shares | $1.4M | 0.62% | 1 |
| KROGER COMPANY (THE) | 501044101 | Equity | CORP | United States | 25,000 | shares | $1.4M | 0.61% | 1 |
| UNITED STATES OF AMERICA - BUREAU OF THE PUBLIC DEBT | 912797UL9 | Debt | UST | United States | 1,400,000 | principal | $1.4M | 0.61% | 2 |
| INFUSYSTEM HOLDINGS INC | 45685K102 | Equity | CORP | United States | 142,085 | shares | $1.4M | 0.60% | 1 |
| UNITED STATES OF AMERICA - BUREAU OF THE PUBLIC DEBT | 912797TP2 | Debt | UST | United States | 1,330,000 | principal | $1.3M | 0.58% | 2 |
| BECTON DICKINSON & COMPANY | 075887109 | Equity | CORP | United States | 8,700 | shares | $1.3M | 0.58% | 1 |
| NEOGENOMICS INC | 64049M209 | Equity | CORP | United States | 90,000 | shares | $1.3M | 0.58% | 1 |
| KRAFT HEINZ COMPANY (THE) | 500754106 | Equity | CORP | United States | 55,000 | shares | $1.3M | 0.57% | 1 |
| SPROUTS FARMERS MARKET INC | 85208M102 | Equity | CORP | United States | 15,000 | shares | $1.3M | 0.56% | 1 |
| ELI LILLY & COMPANY | 532457108 | Equity | CORP | United States | 1,000 | shares | $1.2M | 0.53% | 1 |
| UNITED STATES OF AMERICA - BUREAU OF THE PUBLIC DEBT | 912797TN7 | Debt | UST | United States | 1,200,000 | principal | $1.2M | 0.52% | 2 |
| UNITED STATES OF AMERICA - BUREAU OF THE PUBLIC DEBT | 912797UK1 | Debt | UST | United States | 1,200,000 | principal | $1.2M | 0.52% | 2 |
| CHURCH & DWIGHT CO INC | 171340102 | Equity | CORP | United States | 12,000 | shares | $1.2M | 0.51% | 1 |
| BIO-RAD LABORATORIES INC | 090572207 | Equity | CORP | United States | 3,900 | shares | $1.1M | 0.50% | 1 |
| ABIVAX SA | 00370M103 | Equity | CORP | France | 8,500 | shares | $1.1M | 0.50% | 1 |
| UNITED STATES OF AMERICA - BUREAU OF THE PUBLIC DEBT | 912797UU9 | Debt | UST | United States | 1,120,000 | principal | $1.1M | 0.49% | 2 |
| DAVITA INC | 23918K108 | Equity | CORP | United States | 5,000 | shares | $1.1M | 0.49% | 1 |
| ELEVANCE HEALTH INC | 036752103 | Equity | CORP | United States | 2,700 | shares | $1M | 0.46% | 1 |
| BELLRING BRANDS INC | 07831C103 | Equity | CORP | United States | 80,000 | shares | $1M | 0.45% | 1 |
| VIEMED HEALTHCARE INC | 92663R105 | Equity | CORP | Canada | 85,000 | shares | $969K | 0.42% | 1 |
| MEDTRONIC PLC | IE00BTN1Y115 | Equity | CORP | Ireland | 12,000 | shares | $939K | 0.41% | 1 |
| BRIGHTSPRING HEALTH SERVICES INC | 10950A106 | Equity | CORP | United States | 13,250 | shares | $924K | 0.40% | 1 |
| COLGATE-PALMOLIVE COMPANY | 194162103 | Equity | CORP | United States | 10,000 | shares | $917K | 0.40% | 1 |
| BOSTON SCIENTIFIC CORP | 101137107 | Equity | CORP | United States | 20,650 | shares | $881K | 0.39% | 1 |
| ELANCO ANIMAL HEALTH INC | 28414H103 | Equity | CORP | United States | 35,000 | shares | $861K | 0.38% | 1 |
| INSMED INC | 457669307 | Equity | CORP | United States | 7,500 | shares | $800K | 0.35% | 1 |
| SIMPLY GOOD FOODS COMPANY (THE) | 82900L102 | Equity | CORP | United States | 60,000 | shares | $797K | 0.35% | 1 |
| INTUITIVE SURGICAL INC | 46120E602 | Equity | CORP | United States | 2,000 | shares | $795K | 0.35% | 1 |
| HCA HEALTHCARE INC | 40412C101 | Equity | CORP | United States | 2,000 | shares | $780K | 0.34% | 1 |
| PFIZER INC | 717081103 | Equity | CORP | United States | 32,100 | shares | $773K | 0.34% | 1 |
| GILEAD SCIENCES INC | 375558103 | Equity | CORP | United States | 6,000 | shares | $758K | 0.33% | 1 |
| MONDELEZ INTERNATIONAL INC | 609207105 | Equity | CORP | United States | 13,000 | shares | $752K | 0.33% | 1 |
| GLOBUS MEDICAL INC | 379577208 | Equity | CORP | United States | 9,500 | shares | $751K | 0.33% | 1 |
| REVOLUTION MEDICINES INC | 76155X100 | Equity | CORP | United States | 4,000 | shares | $749K | 0.33% | 1 |
| PROCTER & GAMBLE COMPANY (THE) | 742718109 | Equity | CORP | United States | 5,000 | shares | $733K | 0.32% | 1 |
| CARDINAL HEALTH INC | 14149Y108 | Equity | CORP | United States | 3,000 | shares | $713K | 0.31% | 1 |
| REGENERON PHARMACEUTICALS INC | 75886F107 | Equity | CORP | United States | 1,115 | shares | $695K | 0.30% | 1 |
| CAMPBELL'S COMPANY (THE) | 134429109 | Equity | CORP | United States | 30,000 | shares | $668K | 0.29% | 1 |
| ILLUMINA INC | 452327109 | Equity | CORP | United States | 3,700 | shares | $651K | 0.28% | 1 |
| MEIJI HOLDINGS COMPANY LTD | JP3918000005 | Equity | CORP | Japan | 27,000 | shares | $628K | 0.28% | 1 |
| SURGERY PARTNERS INC | 86881A100 | Equity | CORP | United States | 35,697 | shares | $600K | 0.26% | 1 |
| ALIGNMENT HEALTHCARE INC | 01625V104 | Equity | CORP | United States | 25,000 | shares | $595K | 0.26% | 1 |
| WATERS CORP | 941848103 | Equity | CORP | United States | 1,577 | shares | $591K | 0.26% | 1 |
| UNITED STATES OF AMERICA - BUREAU OF THE PUBLIC DEBT | 912797UZ8 | Debt | UST | United States | 600,000 | principal | $591K | 0.26% | 2 |
| EVOLENT HEALTH INC | 30050B101 | Equity | CORP | United States | 107,500 | shares | $583K | 0.26% | 1 |
| BAXTER INTERNATIONAL INC | 071813109 | Equity | CORP | United States | 23,500 | shares | $501K | 0.22% | 1 |
| TRAVERE THERAPEUTICS INC | 89422G107 | Equity | CORP | United States | 8,300 | shares | $472K | 0.21% | 1 |
| ICON PLC | IE0005711209 | Equity | CORP | Ireland | 2,500 | shares | $434K | 0.19% | 1 |
| LAMB WESTON HOLDINGS INC | 513272104 | Equity | CORP | United States | 10,000 | shares | $432K | 0.19% | 1 |
| MORINAGA MILK INDUSTRY CO LTD | JP3926800008 | Equity | CORP | Japan | 54,000 | shares | $421K | 0.18% | 1 |
| AVANTOR INC | 05352A100 | Equity | CORP | United States | 42,000 | shares | $416K | 0.18% | 1 |
| ITO EN LTD | JP3143000002 | Equity | CORP | Japan | 22,700 | shares | $411K | 0.18% | 1 |
| MEDPACE HOLDINGS INC | 58506Q109 | Equity | CORP | United States | 750 | shares | $397K | 0.17% | 1 |
| ROCHE HOLDING AG | 771195104 | Equity | CORP | Switzerland | 7,700 | shares | $395K | 0.17% | 1 |
| NEKTAR THERAPEUTICS | 640268306 | Equity | CORP | United States | 5,250 | shares | $367K | 0.16% | 1 |
| DEXCOM INC | 252131107 | Equity | CORP | United States | 5,300 | shares | $357K | 0.16% | 1 |
| CHARLES RIVER LABORATORIES INTERNATIONAL INC | 159864107 | Equity | CORP | United States | 1,500 | shares | $340K | 0.15% | 1 |
| WAYSTAR HOLDING CORP | 946784105 | Equity | CORP | United States | 15,000 | shares | $308K | 0.13% | 1 |
| PROTAGONIST THERAPEUTICS INC | 74366E102 | Equity | CORP | United States | 2,500 | shares | $306K | 0.13% | 1 |
| SOLVENTUM CORP | 83444M101 | Equity | CORP | United States | 3,750 | shares | $289K | 0.13% | 1 |
| VITASOY INTERNATIONAL HOLDINGS LTD | HK0345001611 | Equity | CORP | Hong Kong | 350,000 | shares | $289K | 0.13% | 1 |
| ALKERMES PLC | IE00B56GVS15 | Equity | CORP | Ireland | 5,000 | shares | $262K | 0.11% | 1 |
| CYTOKINETICS INC | 23282W605 | Equity | CORP | United States | 3,000 | shares | $256K | 0.11% | 1 |
| HINGE HEALTH INC | 433313103 | Equity | CORP | United States | 3,000 | shares | $249K | 0.11% | 1 |
| AXSOME THERAPEUTICS INC | 05464T104 | Equity | CORP | United States | 1,000 | shares | $245K | 0.11% | 1 |
| KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | GB00BRXB0C07 | Equity | CORP | United Kingdom | 3,750 | shares | $240K | 0.11% | 1 |
| MONOPAR THERAPEUTICS INC | 61023L207 | Equity | CORP | United States | 2,500 | shares | $231K | 0.10% | 1 |
| TARSUS PHARMACEUTICALS INC | 87650L103 | Equity | CORP | United States | 3,600 | shares | $227K | 0.10% | 1 |
| VERICEL CORP | 92346J108 | Equity | CORP | United States | 5,000 | shares | $222K | 0.10% | 1 |
| KAILERA THERAPEUTICS INC | 482931102 | Equity | CORP | United States | 10,000 | shares | $220K | 0.10% | 1 |
| STRUCTURE THERAPEUTICS INC | 86366E106 | Equity | CORP | Cayman Islands | 4,050 | shares | $217K | 0.10% | 1 |
| MAPLE LEAF FOODS INC | 564905107 | Equity | CORP | Canada | 10,000 | shares | $215K | 0.09% | 1 |
| SPYRE THERAPEUTICS INC | 00773J202 | Equity | CORP | United States | 2,250 | shares | $200K | 0.09% | 1 |
| XERIS BIOPHARMA HOLDINGS INC | 98422E103 | Equity | CORP | United States | 25,000 | shares | $198K | 0.09% | 1 |
| QUIDELORTHO CORP | 219798105 | Equity | CORP | United States | 11,200 | shares | $196K | 0.09% | 1 |
| DIANTHUS THERAPEUTICS INC | 252828108 | Equity | CORP | United States | 2,000 | shares | $195K | 0.09% | 1 |
| IMMUNOVANT INC | 45258J102 | Equity | CORP | United States | 5,000 | shares | $193K | 0.08% | 1 |
| RELAY THERAPEUTICS INC | 75943R102 | Equity | CORP | United States | 10,000 | shares | $187K | 0.08% | 1 |
| ERASCA INC | 29479A108 | Equity | CORP | United States | 10,000 | shares | $183K | 0.08% | 1 |
| XENON PHARMACEUTICALS INC | 98420N105 | Equity | CORP | Canada | 3,000 | shares | $181K | 0.08% | 1 |
| IMMUNOME INC | 45257U108 | Equity | CORP | United States | 8,500 | shares | $180K | 0.08% | 1 |
| MIRUM PHARMACEUTICALS INC | 604749101 | Equity | CORP | United States | 1,500 | shares | $176K | 0.08% | 1 |
| VIKING THERAPEUTICS INC | 92686J106 | Equity | CORP | United States | 4,400 | shares | $172K | 0.08% | 1 |
| ROYALTY PHARMA PLC | GB00BMVP7Y09 | Equity | CORP | United Kingdom | 3,000 | shares | $168K | 0.07% | 1 |
| SCHOLAR ROCK HOLDING CORP | 80706P103 | Equity | CORP | United States | 3,000 | shares | $165K | 0.07% | 1 |
| MINERALYS THERAPEUTICS INC | 603170101 | Equity | CORP | United States | 6,000 | shares | $162K | 0.07% | 1 |
| MADRIGAL PHARMACEUTICALS INC | 558868105 | Equity | CORP | United States | 300 | shares | $161K | 0.07% | 1 |
| CELCUITY INC | 15102K100 | Equity | CORP | United States | 1,500 | shares | $157K | 0.07% | 1 |
| UNIQURE NV | NL0010696654 | Equity | CORP | Netherlands | 3,300 | shares | $152K | 0.07% | 1 |
| VERA THERAPEUTICS INC | 92337R101 | Equity | CORP | United States | 3,500 | shares | $150K | 0.07% | 1 |
| TINGYI (CAYMAN ISLANDS) HOLDING CORP | KYG8878S1030 | Equity | CORP | Cayman Islands | 120,000 | shares | $150K | 0.07% | 1 |
| PERRIGO COMPANY PLC | IE00BGH1M568 | Equity | CORP | Ireland | 14,000 | shares | $145K | 0.06% | 1 |
| HEALTHEQUITY INC | 42226A107 | Equity | CORP | United States | 1,600 | shares | $145K | 0.06% | 1 |
| COGENT BIOSCIENCES INC | 19240Q201 | Equity | CORP | United States | 3,500 | shares | $135K | 0.06% | 1 |
| EVOMMUNE INC | 30054Y107 | Equity | CORP | United States | 9,500 | shares | $126K | 0.06% | 1 |
| ORUKA THERAPEUTICS INC | 687604108 | Equity | CORP | United States | 1,250 | shares | $119K | 0.05% | 1 |
| MEDLINE INC | 58507V107 | Equity | CORP | United States | 3,000 | shares | $118K | 0.05% | 1 |
| ORTHOFIX MEDICAL INC | 68752M108 | Equity | CORP | United States | 12,500 | shares | $114K | 0.05% | 1 |
| PROCEPT BIOROBOTICS CORP | 74276L105 | Equity | CORP | United States | 5,000 | shares | $113K | 0.05% | 1 |
| NEOGEN CORP | 640491106 | Equity | CORP | United States | 12,000 | shares | $108K | 0.05% | 1 |
| ZEVRA THERAPEUTICS INC | 488445206 | Equity | CORP | United States | 7,500 | shares | $108K | 0.05% | 1 |
| CHINA MENGNIU DAIRY COMPANY LTD | KYG210961051 | Equity | CORP | Cayman Islands | 50,000 | shares | $103K | 0.04% | 1 |
| BIOCRYST PHARMACEUTICALS INC | 09058V103 | Equity | CORP | United States | 10,000 | shares | $100K | 0.04% | 1 |
| KYMERA THERAPEUTICS INC | 501575104 | Equity | CORP | United States | 850 | shares | $97.5K | 0.04% | 1 |
| BAUSCH HEALTH COMPANIES INC | 071734107 | Equity | CORP | Canada | 17,500 | shares | $86.3K | 0.04% | 1 |
| ALIGN TECHNOLOGY INC | 016255101 | Equity | CORP | United States | 500 | shares | $84.3K | 0.04% | 1 |
| GRAIL INC | 384747101 | Equity | CORP | United States | 1,200 | shares | $81.9K | 0.04% | 1 |
| GUARDANT HEALTH INC | 40131M109 | Equity | CORP | United States | 500 | shares | $75K | 0.03% | 1 |
| INSPIRE MEDICAL SYSTEMS INC | 457730109 | Equity | CORP | United States | 1,500 | shares | $66.9K | 0.03% | 1 |
| AVITA MEDICAL INC | 05380C102 | Equity | CORP | United States | 15,000 | shares | $62K | 0.03% | 1 |
| MISSION PRODUCE INC | 60510V108 | Equity | CORP | United States | 4,895 | shares | $57.7K | 0.03% | 1 |
| ATRICURE INC | 04963C209 | Equity | CORP | United States | 2,000 | shares | $56K | 0.02% | 1 |
| MERSANA THERAPEUTICS INC | ticker MRSN | Equity | CORP | United States | 27,000 | shares | $47.3K | 0.02% | 2 |
| TANDEM DIABETES CARE INC | 875372203 | Equity | CORP | United States | 3,000 | shares | $45.3K | 0.02% | 1 |
| IDEXX LABORATORIES INC | 45168D104 | Equity | CORP | United States | 65 | shares | $34.2K | 0.01% | 1 |
| ONCOLOGY INSTITUTE INC | 68236X100 | Equity | CORP | United States | 5,600 | shares | $30.4K | 0.01% | 1 |
| DENALI THERAPEUTICS INC | 24823R105 | Equity | CORP | United States | 1,000 | shares | $25.7K | 0.01% | 1 |
| IONIS PHARMACEUTICALS INC | 462222100 | Equity | CORP | United States | 300 | shares | $23.8K | 0.01% | 1 |
| LUCID DIAGNOSTICS INC | 54948X109 | Equity | CORP | United States | 19,500 | shares | $20.9K | 0.01% | 1 |
| BICARA THERAPEUTICS INC | 055477103 | Equity | CORP | United States | 650 | shares | $19.3K | 0.01% | 1 |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | Equity | CORP | United States | 100 | shares | $16.9K | 0.01% | 1 |
| CENTESSA PHARMACEUTICALS PLC | ticker CNTA | Equity | CORP | United States | 7,500 | shares | $15K | 0.01% | 2 |
| Akero Therapeutics Inc | 009CVR044 | Equity | CORP | United States | 28,500 | shares | $14.3K | 0.01% | 2 |
| LIFESTANCE HEALTH GROUP INC | 53228F101 | Equity | CORP | United States | 1,000 | shares | $10.7K | 0.00% | 1 |
| NVIDIA CORP | 67066G104 | Equity | CORP | United States | 50 | shares | $10K | 0.00% | 1 |
| WALGREENS BOOTS ALLIANCE INC | ticker WBA | Equity | CORP | United States | 20,000 | shares | $10K | 0.00% | 2 |
| DANAHER CORP | 235851102 | Equity | CORP | United States | 50 | shares | $9.5K | 0.00% | 1 |
| CHINOOK THERAPEUTICS INC | 169CVR016 | Equity | CORP | United States | 38,284 | shares | $7.7K | 0.00% | 2 |
| PERSONALIS INC | 71535D106 | Equity | CORP | United States | 500 | shares | $6.7K | 0.00% | 1 |
| DBV TECHNOLOGIES SA | 23306J309 | Equity | CORP | France | 400 | shares | $6.6K | 0.00% | 1 |
| ANNEXON INC | 03589W102 | Equity | CORP | United States | 1,000 | shares | $5.7K | 0.00% | 1 |
| ASTRANA HEALTH INC | 03763A207 | Equity | CORP | United States | 100 | shares | $4.6K | 0.00% | 1 |
| QIAGEN NV | NL0015002SN0 | Equity | CORP | Netherlands | 100 | shares | $3.9K | 0.00% | 1 |
| GENEDX HOLDINGS CORP | 81663L200 | Equity | CORP | United States | 50 | shares | $3.4K | 0.00% | 1 |
| MAZE THERAPEUTICS INC | 578784100 | Equity | CORP | United States | 100 | shares | $3K | 0.00% | 1 |
| UPSTREAM BIO INC | 91678A107 | Equity | CORP | United States | 400 | shares | $2.8K | 0.00% | 1 |
| REGENXBIO INC | 75901B107 | Equity | CORP | United States | 100 | shares | $1.2K | 0.00% | 1 |
| Paratek Pharmaceuticals CVR | — | Equity | CORP | United States | 13,000 | shares | $260 | 0.00% | 2 |
| BIOGEN INC - CVR | — | Equity | CORP | United States | 5,000 | shares | $50 | 0.00% | 2 |
Equities show share counts; bonds and loans show principal amount. Coupon, maturity and ratings are shown where the filing discloses them. Source: SEC N-PORT via market-data vendor re-serve, position-level.
Holdings reports on file
| Report date | Filed | Positions | Σ weight | Net assets (calc.) | Coverage |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 31, 2026 | 195 | 100.0% | $228M | full |
| Mar 31, 2026 | Jun 1, 2026 | 194 | 100.0% | $230M | full |
| Dec 31, 2025 | Mar 2, 2026 | 182 | 100.0% | $241M | full |
Net assets here are calculated from position values ÷ reported weights (median across positions), not a reported figure.
CEF Explorer research page for Gabelli Healthcare & WellnessRx Trust. Figures carry their own dates and sources; a discount to NAV does not guarantee convergence or any return. This is not investment advice.